American Diabetes Association Says Mifepristone Shown To Reduce A1C In Patients With Difficult-To-Control Type 2 Diabetes And Hypercortisolism
Refinitiv1分未満で読めます
AMERICAN DIABETES ASSOCIATION: MIFEPRISTONE SHOWN TO REDUCE A1C IN PATIENTS WITH DIFFICULT-TO-CONTROL TYPE 2 DIABETES AND HYPERCORTISOLISM
ログイン、もしくは永年無料のアカウントを作成して、このニュースを読みましょう